Take control of your chronic lower back pain.
The RelieVRx™ program is the first FDA-authorized in-home virtual reality (VR) treatment clinically proven to significantly reduce CLBP.1,2,3
SEE THE PROOF
The RelieVRx program is a non-pharmacologic form of chronic lower back pain relief
The RelieVRx program is a self-guided, in-home program
Daily sessions consist of established pain management techniques such as body awareness, pain distraction, relaxation, and behavior modification.1
Immersive VR sessions are used over 8 weeks for an average of 6 minutes a day
Each session builds upon the last, prompting neuroplasticity—the brain’s ability to modify, change, and adapt in response to experience. The RelieVRx program is easy to use and has high user satisfaction.3
Chronic Lower Back Pain Suffers Need Lasting Relief
Chronic lower back pain patients typically take more medications than the average patient, which may include opioids4. Opioids can cause complications or side effects and are not an effective long term treatment for chronic lower back pain5. A comprehensive approach is needed to improve patient lives.
Learn how a new approach may help address the gap in treatment.
Sign up for information
Stay on cutting edge of chronic lower back pain management by subscribing to receive updated about the RelieVRx program.
If you are a current RelieVRx patient and need support, call us at
Monday through Friday, 9am-7pm EDT
or email us at: support@avrpathway.com
Indication for Use
The RelieVRx program is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back-pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.
Contraindications
There are no known contraindications.
References
- RelieVRx [instructions for use]. Van Nuys, CA: AppliedVR, Inc.; 2021.
- “Device Classification under Section 513(F)(2)(De Novo).” Accessdata.fda.gov.
- Garcia LM, Birckhead BJ, Krishnamurthy P, et al. An 8-week self-administered at-home behavioral skills-based virtual reality program for chronic low back pain: double-blind, randomized, placebo-controlled trial conducted during COVID-19. J Med Internet Res. 2021;23(2):e26292. doi:10.2196/26292
- Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine (Phila Pa 1976). 2012;37(11):E668-E677
- Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015;350:g6380.